$2.0B
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | PRAX Praxis Precision Medicines I | 640,000 | −27.7% | $214M | 11.0% |
| 2 | BBOT Bridgebio Oncology Therapeut | 17.9M | +0.0% | $136M | 7.0% |
| 3 | PBLS Parabilis Medicines Inc | 4.6M | — | $126M | 6.5% |
| 4 | RAPP Rapport Therapeutics Inc | 2.7M | −10.1% | $111M | 5.7% |
| 5 | ERAS Erasca Inc | 6.0M | +3.4% | $110M | 5.6% |
| 6 | EWTX Edgewise Therapeutics Inc | 2.5M | −23.0% | $102M | 5.2% |
| 7 | EYPT Eyepoint Inc | 7.0M | −15.3% | $100M | 5.1% |
| 8 | ALMS Alumis Inc | 3.3M | −16.8% | $92M | 4.7% |
| 9 | ABIVAX SA Abivax Sa | 675,000 | −11.2% | $90M | 4.6% |
| 10 | DNTH Dianthus Therapeutics Inc | 750,000 | −21.1% | $73M | 3.7% |
| 11 | DRUG Bright Minds Biosciences Inc | 900,000 | −15.0% | $63M | 3.2% |
| 12 | MLTX Moonlake Immunotherapeutics | 3.2M | −28.5% | $62M | 3.2% |
| 13 | BIOA Bioage Labs Inc | 2.4M | −17.3% | $59M | 3.0% |
| 14 | ORKA Oruka Therapeutics Inc | 533,340 | +0.0% | $51M | 2.6% |
| 15 | ANL Adlai Nortye Ltd | 4.0M | +37.3% | $46M | 2.3% |
| 16 | BBIO Bridgebio Pharma Inc | 550,000 | −35.3% | $41M | 2.1% |
| 17 | TNGX Tango Therapeutics Inc | 1.3M | −8.8% | $41M | 2.1% |
| 18 | BHVN Biohaven Ltd | 2.6M | +48.3% | $39M | 2.0% |
| 19 | AGMB Agomab Therapeutics Nv | 2.5M | +0.0% | $32M | 1.6% |
| 20 | MBX Mbx Biosciences Inc | 550,000 | −50.9% | $30M | 1.6% |
| 21 | CLYM Climb Bio Inc | 2.1M | — | $27M | 1.4% |
| 22 | OLEMA PHARMACEUTICALS INC Olema Pharmaceuticals Inc | 2.1M | −44.9% | $27M | 1.4% |
| 23 | DMRA Damora Therapeutics Inc | 1.0M | −34.4% | $26M | 1.3% |
| 24 | PHVS Pharvaris N V | 750,000 | −25.0% | $26M | 1.3% |
| 25 | CRBP Corbus Pharmaceuticals Hldgs | 2.3M | +0.0% | $22M | 1.1% |
| 26 | SYRE Spyre Therapeutics Inc | 225,000 | — | $20M | 1.0% |
| 27 | DFTX Definium Therapeutics Inc | 400,000 | — | $19M | 1.0% |
| 28 | NAMS Newamsterdam Pharma Company | 500,000 | −47.4% | $17M | 0.9% |
| 29 | ROIV Roivant Sciences Ltd | 475,000 | −36.7% | $17M | 0.9% |
| 30 | CABA Cabaletta Bio Inc | 5.0M | −9.1% | $16M | 0.8% |
| 31 | HLXC Helix Acquisition Corp Iii | 1.3M | +0.0% | $14M | 0.7% |
| 32 | ASND Ascendis Pharma A/S | 50,000 | — | $13M | 0.7% |
| 33 | KLRA Kailera Therapeutics Inc | 550,000 | — | $12M | 0.6% |
| 34 | INSM Insmed Inc | 75,000 | −60.5% | $8M | 0.4% |
| 35 | FTH Faeth Therapeutics Inc | 1.0M | +235.8% | $8M | 0.4% |
| 36 | ELVN Enliven Therapeutics Inc | 150,000 | — | $8M | 0.4% |
| 37 | TARS Tarsus Pharmaceuticals Inc | 100,000 | −55.6% | $6M | 0.3% |
| 38 | IBIO Ibio Inc | 3.6M | — | $6M | 0.3% |
| 39 | CRINETICS PHARMACEUTICALS IN Crinetics Pharmaceuticals In | 125,000 | −50.0% | $5M | 0.2% |
| 40 | ARQT Arcutis Biotherapeutics Inc | 175,000 | −61.1% | $5M | 0.2% |
| 41 | ARWR Arrowhead Pharmaceuticals In | 50,000 | −50.0% | $4M | 0.2% |
| 42 | GPCR Structure Therapeutics Inc | 75,000 | −57.1% | $4M | 0.2% |
| 43 | RACC Research Alliance Corp Iii | 370,000 | — | $4M | 0.2% |
| 44 | COGT Cogent Biosciences Inc | 100,000 | −50.0% | $4M | 0.2% |
| 45 | ALT Altimmune Inc | 1.2M | — | $4M | 0.2% |
| 46 | AMLX Amylyx Pharmaceuticals Inc | 200,000 | −42.9% | $4M | 0.2% |
| 47 | ODTX Odyssey Therapeutics Inc | 175,000 | — | $3M | 0.2% |
| 48 | PCVX Vaxcyte Inc | 50,000 | −50.0% | $3M | 0.1% |
| 49 | BOLD Boundless Bio Inc | 1.0M | — | $2M | 0.1% |
| 50 | QUINCE THERAPEUTICS INC Quince Therapeutics Inc | 5,498 | — | $100,009 | 0.0% |